← Leaderboards
Ruobing Wang
Boston Children'S Hospital
$1,648,862
Attributed
$1,648,862
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $977.1K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,648,862 · 2
By mechanism
K08$839,700 · 1
R01$809,162 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Daniel Evan Bauer$19,160,492
- Jessica Garbern$351,962
- Scot A Wolfe$14,652,054
- Nathan James Vandusen$1,863,475
- Sarah Morton$1,124,028
Others in their field
Other Emerging Leaders on “Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$195,683,539
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
Research focus
ResponseCystic FibrosisGenesProtocols DocumentationSingle-Cell Rna SequencingViscosityDefectFutureIn Vitro ModelMucociliary ClearanceCystic Fibrosis Transmembrane Conductance RegulatorBasal CellAirway EpitheliumStem CellsBiologyChloridesCellsDelta F508 MutationInduced Pluripotent Stem CellIn VitroIonsLiquid SubstanceBiological ModelsCystic Fibrosis Airway Epithelia
Grant awards (6)
Investigating pulmonary ionocyte function and development using iPSCs$809,162
R01 · FY2025 · HL · contact PI
Using Induced Pluripotent Stem Cells to Characterize Cystic Fibrosis$167,940
K08 · FY2025 · HL · contact PI
Using Induced Pluripotent Stem Cells to Characterize Cystic Fibrosis$167,940
K08 · FY2024 · HL · contact PI
Using Induced Pluripotent Stem Cells to Characterize Cystic Fibrosis$167,940
K08 · FY2023 · HL · contact PI
Using Induced Pluripotent Stem Cells to Characterize Cystic Fibrosis$167,940
K08 · FY2022 · HL · contact PI
Using Induced Pluripotent Stem Cells to Characterize Cystic Fibrosis$167,940
K08 · FY2021 · HL · contact PI